Around the world, pharmaceutical companies and governments are working at record speed to develop a vaccine for the novel coronavirus. There are currently more...
GlaxoSmithKline (LON:GSK) have seen their profits rise across 2019 as the pharmaceutical titan updated the market on its 2019 and fourth quarter operations.
Glaxo alluded...
FTSE 250 specialist pharmaceutical company Indivior Plc (LON:INDV) announced on Wednesday that it has released an authorised generic version of its treatment to combat...
British pharmaceutical firm GlaxoSmithKline (LON:GSK) have posted a 36% on-year hike in full-year profits, though the company have warned investors of the potential for...
GlaxoSmithKline Plc (LON:GSK) have secured approval for a licence extension of their Nucala treatment for children with severe asthma.
The treatment was first received patent...
GlaxoSmithKline (LON:GSK) continues to rally and avoid the more bleak fate being faced by some of its FTSE 100 counterparts.
GSK's share price has progressed...
The coronavirus pandemic devastated not only International Consolidated Airlines (IAG) (LON:IAG), but the airline sector more generally. Heathrow confirmed a £2bn loss during 2020...
GRIT Real Estate Income Group is a leading pan-African property investment company with an actively managed and diversified portfolio of assets worth $849.2m.
There are...
Sandrine Zerbib, founder of Chinese online consumer platform Full Jet, joins the UK Investor Magazine Podcast to discuss key Chinese consumer trends and the evolution...
